A Cost Effectivness Analysis of Everolimus Compared with Axitinib in the Treatment of Metastatic Renal Cell Carcinoma in the United Kingdom
Nov 1, 2014, 00:00
10.1016/j.jval.2014.08.2308
https://www.valueinhealthjournal.com/article/S1098-3015(14)04238-7/fulltext
Title :
A Cost Effectivness Analysis of Everolimus Compared with Axitinib in the Treatment of Metastatic Renal Cell Carcinoma in the United Kingdom
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)04238-7&doi=10.1016/j.jval.2014.08.2308
First page :
A640
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
1764